1-20 of 53
Joseph Mikhael
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Advancing Patient-Centered Care to Overcome Health Disparities in Multiple Myeloma: Key Findings from a Quality Improvement Initiative

Joseph Mikhael, Cesar Rodriguez, Amy E. Pierre, M. Sarfraz Nawaz, Ellie Moses-Okwei, Lindsay Gurska, Emily Zyborowicz, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen
Journal: Blood
Blood (2024) 144 (Supplement 1): 5034.
https://doi.org/10.1182/blood-2024-203674
Published: 2024
Journal Articles

Evidence of Improved Knowledge and Skills Among Hematologists/Oncologists Participating in Online CME-Certified Activities

Lauren Willis, Emily S. Van Laar, Tristin Abair, Megan Whitney, Caitlin Costello, Amrita Y. Krishnan, Sagar Lonial, Sandra Kurtin, Joseph Mikhael, Ola Landgren
Journal: Blood
Blood (2021) 138 (Supplement 1): 4958.
https://doi.org/10.1182/blood-2021-145375
Published: 2021
Journal Articles

High-Risk Gene Expression Subtype Provides Molecular Basis for Different Clinical Presentation of Primary and Secondary Plasma Cell Leukemia

Sheri Skerget, Daniel Penaherrera, Joseph Mikhael, Jonathan J Keats
Journal: Blood
Blood (2021) 138 (Supplement 1): 726.
https://doi.org/10.1182/blood-2021-148138
Published: 2021
Journal Articles

Understanding Root Causes Contributing to Real-World Racial Disparities in Multiple Myeloma Care: Insights from a Mixed-Methods Study Utilizing Tethered Patient-Provider Surveys and Chart Reviews

Joseph Mikhael, MD FRCPC, MD, Anne Jacobson, MS, Jeffrey D Carter, PhD, Tamar Sapir, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-136750
Published: 2020
Journal Articles

Real-World Renal Function Among Patients with Multiple Myeloma in the United States

Joseph Mikhael, MD FRCPC, MD, Erin Singh, Megan Rice, ScD, MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-136630
Published: 2020
Journal Articles

Depth of Response and Response Kinetics of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma: Ikema Interim Analysis

Thomas Martin, MD, Joseph Mikhael, MD FRCPC, MD, Roman Hajek, MD, Kihyun Kim, MD PhD, Kenshi Suzuki, MD PhD, Cyrille Hulin, MD, Mamta Garg, MD FRCP, FRCPath, Hang Quach, MDFRACP,FRCPA,MBBS, Hanlon Sia, Anup George, Tatiana Konstantinova, MD PhD, Marie-Laure Risse, Gaelle Asset, Sandrine Macé, Helgi van de Velde, MD PhD, Philippe Moreau, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
https://doi.org/10.1182/blood-2020-137681
Published: 2020
Journal Articles

Pilot Trial of the My Hematology Oncology Patient Experience (MyHOPE™) for Multiple Myeloma (MM) Digital Solution in Patients with MM

Noopur S. Raje, MD, Omar Nadeem, MD, Joseph Mikhael, MD FRCPC, MD, Catherine Ludwig, MB BChir, Amit Agarwal, MD PhD, Judith Inumerable, PGC, Teng J. Ong, MD, Sundar Jagannath, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–4.
https://doi.org/10.1182/blood-2020-141591
Published: 2020
Journal Articles

The Global State of Hematopoietic Stem Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation (WBMT) Database and the Global Burden of Disease Study

Andrew J. Cowan, MD, Helen Baldomero, Yoshiko Atsuta, MD PhD, Joseph Mikhael, MD FRCPC, MD, Mahmoud Aljurf, Adriana Seber, MD, Hildegard T. Greinix, MD, Mickey Koh, MD PhD, Nina Worel, MD, Edward N. Libby, III, MD, Marcelo C. Pasquini, MD, Sebastian Galeano, MD, Gregorio Jaimovich, Juliana Martinez Rolon, MD, Yoshihisa Kodera, MD, Malek Benakli, MD PhD, Bazuaye G Nosakhare, MD, Alaa M. Elhaddad, MD, Jeffrey Szer, MBBS, Jakob R. Passweg, MDMS, Nicolaus Kroeger, MD, Daniel J. Weisdorf, MD, Dietger Niederwieser, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 412.
https://doi.org/10.1182/blood-2019-126837
Published: 2019
Journal Articles

The Relationship between Baseline Biomarkers and Efficacy of Isatuximab in Combination with Pomalidomide and Dexamethasone in RRMM: Insights from Phase 1 and Phase 3 Studies

Paul G. Richardson, MD, Joseph Mikhael, MD FRCPC, MD, Thierry Facon, MD, William I. Bensinger, Sandrine Macé, Marielle Chiron, Helgi van de Velde, MD PhD, Frank Campana, MD, Li Liu, Michel Attal, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3179.
https://doi.org/10.1182/blood-2019-128071
Published: 2019
Journal Articles

A phase 1b study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma

Clinical Trials & Observations
Joseph Mikhael, Paul Richardson, Saad Z. Usmani, Noopur Raje, William Bensinger, Chatchada Karanes, Frank Campana, Dheepak Kanagavel, Franck Dubin, Qianying Liu, Dorothée Semiond, Kenneth Anderson
Journal: Blood
Blood (2019) 134 (2): 123–133.
https://doi.org/10.1182/blood-2019-02-895193
Published: 2019
Journal Articles

Patient Treatment Preferences for Relapsed/Refractory Multiple Myeloma: Are Patients Willing to Trade Off Efficacy for Tolerability?

Daniel Auclair, PhD, Carol Mansfield, PhD, Ajai Chari, MD, Craig E. Cole, MD, Mark A. Fiala, BS, Jonathan L Kaufman, MD, Gregory Orloff, MD, David S Siegel, MD PhD, Jeffrey A Zonder, MD, Brennan Mange, Jennifer Yesil, MS, Mehul Dalal, PhD, Joseph Mikhael, MD FRCPC, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 614.
https://doi.org/10.1182/blood-2018-99-113087
Published: 2018
Journal Articles

Predicting Risk of Venous Thromboembolism in Multiple Myeloma: The Impede VTE Score

Kristen M. Sanfilippo, MD, Suhong Luo, MS, Tzu-Fei Wang, MD, Tanya Wildes, MD, Joseph Mikhael, MD FRCPC, MD, Jesse W. Keller, MD MPHS, Theodore S. Thomas, MD MPHS, Kenneth R. Carson, MD PhD, Brian F. Gage, MD MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 141.
https://doi.org/10.1182/blood-2018-99-116300
Published: 2018
Journal Articles

Carfilzomib in Relapsed or Refractory Multiple Myeloma Patients with Early or Late Relapse Following Prior Therapy: A Subgroup Analysis of the Randomized Phase 3 Aspire and Endeavor Trials

Maria-Victoria Mateos, Hartmut Goldschmidt, MD, Jesus F San Miguel, MD PhD, Joseph Mikhael, MD, Lucy DeCosta, MSc, Lifen Zhou, Mihaela Obreja, Julie Blaedel, Zsolt Szabo, MD, Xavier Leleu, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3120.
https://doi.org/10.1182/blood.V130.Suppl_1.3120.3120
Published: 2017
Journal Articles

Phase 1 Study of Venetoclax in Combination with Dexamethasone As Targeted Therapy for t(11;14) Relapsed/Refractory Multiple Myeloma

Jonathan L. Kaufman, MD, Cristina J. Gasparetto, MD, Joseph Mikhael, MD, Philippe Moreau, MDPhD, Cyrille Touzeau, MD PhD, Ravi Vij, MDMBA, Thierry Facon, MD, Brigitte Pegourie, MD, Lofti Benboubker, MD, Lawrence H. Boise, PhD, Stefanie Alzate, MSc, Martin Dunbar, DRPH, MS, Jia Jia, PhD MBA, Kevin J. Freise, PhD, Maria Verdugo, MD, Jeremy Ross, PhD MBA, Paulo Maciag, MD PhD, Shaji K Kumar, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3131.
https://doi.org/10.1182/blood.V130.Suppl_1.3131.3131
Published: 2017
Journal Articles

Updated Results from a Phase Ib Study of Isatuximab Plus Pomalidomide (Pom) and Dexamethasone (dex) in Relapsed/Refractory Multiple Myeloma (RRMM)

Paul G Richardson, MD, Joseph Mikhael, MD, Saad Z Usmani, MD, Noopur Raje, MD, William Bensinger, MD, Dheepak Kanagavel, MD PhD, Lei Gao, Samira Ziti-Ljajic, Kenneth C Anderson, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1887.
https://doi.org/10.1182/blood.V130.Suppl_1.1887.1887
Published: 2017
Journal Articles

Relapsed or Refractory Multiple Myeloma Patients Treated with Second-Line Carfilzomib and Categorized By Prior Exposure to Bortezomib: A Subgroup Analysis of the Randomized Phase 3 Aspire and Endeavor Trials

Maria-Victoria Mateos, Hartmut Goldschmidt, MD, Jesus F San Miguel, MD PhD, Joseph Mikhael, MD, Lifen Zhou, Mihaela Obreja, Julie Blaedel, Karim Saad Iskander, Xavier Leleu, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1840.
https://doi.org/10.1182/blood.V130.Suppl_1.1840.1840
Published: 2017
Journal Articles

Understanding the Preferences of Patients and Caregivers for Relapsed/Refractory Multiple Myeloma Treatment: A Mixed-Mode Patient-Centric Approach

Daniel Auclair, PhD, Carol Mansfield, PhD, Ajai Chari, MD, Craig E. Cole, MD, Mark A. Fiala, BS, Jonathan L. Kaufman, MD, Gregory Orloff, MD, David Siegel, MD PhD, Jeff A. Zonder, MD, Brennan Mange, Jennifer Yesil, MS, Mehul Dalal, PhD, Joseph Mikhael, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5662.
https://doi.org/10.1182/blood.V130.Suppl_1.5662.5662
Published: 2017
Journal Articles

Determinants of Hematology-Oncology Trainee's Post-Fellowship Career Pathways with a Focus on Non-Malignant Hematology

Ariela L. Marshall, MD, Sarah Jenkins, MS, Joseph Mikhael, MD MD FRCPC, Scott D. Gitlin, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3365.
https://doi.org/10.1182/blood.V130.Suppl_1.3365.3365
Published: 2017
Journal Articles

Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma

Clinical Trials & Observations
Shaji Kumar, Jonathan L. Kaufman, Cristina Gasparetto, Joseph Mikhael, Ravi Vij, Brigitte Pegourie, Lofti Benboubker, Thierry Facon, Martine Amiot, Philippe Moreau, Elizabeth A. Punnoose, Stefanie Alzate, Martin Dunbar, Tu Xu, Suresh K. Agarwal, Sari Heitner Enschede, Joel D. Leverson, Jeremy A. Ross, Paulo C. Maciag, Maria Verdugo, Cyrille Touzeau
Journal: Blood
Blood (2017) 130 (22): 2401–2409.
https://doi.org/10.1182/blood-2017-06-788786
Published: 2017
Includes: Supplemental data
Journal Articles

Pee no more? Urine light chains down the drain

Joseph Mikhael
Journal: Blood
Blood (2016) 128 (25): 2873–2874.
https://doi.org/10.1182/blood-2016-10-746883
Published: 2016